Similar articles

• Risk of Psychiatric and Neurodevelopmental Disorders Among Siblings of Probands With Autism Spectrum Disorders.

  Jokiranta-Olkoniemi E, Cheslack-Postava K, Sucksdorff D, Suominen A, Gyllenberg D, Chudal R, Leivonen S, Gissler M, Brown AS, Sourander A. Jokiranta-Olkoniemi E, et al. JAMA Psychiatry. 2016 Jun 1;73(6):622-9. doi: 10.1001/jamapsychiatry.2016.0495. JAMA Psychiatry. 2016. PMID: 27145529
• Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL-α, induces autism spectrum disorder-like and co-morbid phenotypes in adult C57BL/J mice.

  Fyke W, Alarcon JM, Velinov M, Chadman KK. Fyke W, et al. Autism Res. 2021 Jul;14(7):1375-1389. doi: 10.1002/aur.2520. Epub 2021 Apr 21. Autism Res. 2021. PMID: 33886158
• Sex differences in neurodevelopmental disorders.

  May T, Adesina I, McGillivray J, Rinehart NJ. May T, et al. Curr Opin Neurol. 2019 Aug;32(4):622-626. doi: 10.1097/WCO.0000000000000714. Curr Opin Neurol. 2019. PMID: 31135460 Review.
• Mesenchymal stem cells in autism spectrum and neurodevelopmental disorders: pitfalls and potential promises.

  Simberlund J, Ferretti CJ, Hollander E. Simberlund J, et al. World J Biol Psychiatry. 2015 Sep;16(6):368-375. doi: 10.3109/15622975.2015.1067372. Epub 2015 Jul 31. World J Biol Psychiatry. 2015. PMID: 26230216
• Clinical effectiveness of repetitive transcranial magnetic stimulation treatment in children and adolescents with neurodevelopmental disorders: A systematic review.

  Masuda F, Nakajima S, Miyazaki T, Tarumi R, Ogyu K, Wada M, Tsugawa S, Croarkin PE, Mimura M, Noda Y. Masuda F, et al. Autism. 2019 Oct;23(7):1614-1629. doi: 10.1177/1362361318822502. Epub 2019 Jan 20. Autism. 2019. PMID: 30663323